Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?

Saved in:
Bibliographic Details
Title: Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?
Authors: Diamant, André1 andre.diamantboustead@mail.mcgill.ca, Chatterjee, Avishek1, Faria, Sergio1, Naqa, Issam El1, Bahig, Houda1, Filion, Edith1, Robinson, Cliff1, Al-Halabi, Hani1, Seuntjens, Jan1
Source: Radiotherapy & Oncology. Sep2018, Vol. 128 Issue 3, p513-519. 7p.
Database: Academic Search Ultimate
Description
ISSN:01678140
DOI:10.1016/j.radonc.2018.05.012